SCHEMBL10104740

SCHEMBL10104740

Cc1cccc(Cn2cc(-c3nc4c(c(=O)n(C)c(=O)n4C)n3C)nn2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.57
MAOA P21397 4/20 0.57
ALDH1A1 P00352 8/20 0.54
LMNA P02545 6/20 0.54
GAA P10253 2/20 0.54
SMN1; SMN2 Q16637 4/20 0.52
TSHR P16473 4/20 0.52
HTT P42858 4/20 0.52
MAPK1 P28482 3/20 0.52
ATM Q13315 1/20 0.52
GFER P55789 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
HSD17B10 Q99714 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
KDM4E B2RXH2 2/20 0.51
USP2 O75604 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9904085 0.87 MAOB (0.59) MAOBMAOALMNAGAASMN1; SMN2
SCHEMBL17786245 0.73 SMN1; SMN2 (0.71) MAOBMAOAALDH1A1LMNAGAA
SCHEMBL17786270 0.72 LMNA (0.64) MAOBMAOAALDH1A1LMNAGAA
SCHEMBL10104773 0.71 ADORA2A (0.51)
SCHEMBL30185437 0.71 CYP19A1 (0.72) SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL29275463 0.71 CYP19A1 (0.72) SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL14623976 0.70 LMNA (0.84) ALDH1A1LMNAGAASMN1; SMN2TSHR
SCHEMBL13939659 0.69 ALDH1A1 (0.80) MAOBALDH1A1LMNAGAASMN1; SMN2
SCHEMBL16029691 0.69 LMNA (0.63) MAOBMAOAALDH1A1LMNAGAA
SCHEMBL10104730 0.69 ADORA2B (0.60) ALDH1A1TSHRMAPK1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed